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37(Shangjuxu) improves function of the
enteric nervous system in a novel mouse
constipation model
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Abstract
Background: Electroacupuncture (EA) at acupoint ST 37 (Shangjuxu) has been used to alleviate gastrointestinal
symptoms and improve gastrointestinal motility. However, the mechanisms by which EA affects the enteric nervous
system (ENS) have scarcely been investigated. In this study, we investigated whether EA could improve ENS function.
Methods: A constipation model was established by gastric instillation of ice-cold saline daily for 14 days. The
constipated mice were divided into two groups: the model group, which was not treated, and the EA group, which
received EA at ST 37 at a frequency of 2–15 HZ and an amplitude of 1 mA for 15 min a day for 3 days. A further six
mice were included as a non-constipated control group. After EA treatment, intestinal propulsion and defecation time
were measured. Additionally, in jejunum, ileum and proximal colon myenteric plexus, the expressions of PGP9.5 and
nNOS were measured by immunohistochemistry.
Results: The EA group demonstrated significant improvements in carbon propulsion rates and defecation time
compared to model group (P < 0.05). In addition, after EA, the PGP9.5 and nNOS expression in jejunum, ileum and
proximal colonic myenteric plexus was back to normal levels.
Conclusion: This study suggests that EA stimulation at ST 37 is capable of ameliorating intestinal motility dysfunction,
and can partly restore enteric neuron function. The ENS can participate in changes in intestinal motility by affecting
inhibitory neurons.
Keywords: Electroacupuncture(EA), Enteric nervous system(ENS), Gastrointestinal (GI), Neuronal nitric oxide synthase
(nNOS)
Background
Constipation is a symptom of underlying defects in transit
of fecal mass through the gut or in defecation, and is a
commonly diagnosed functional gastrointestinal (GI)
disorder. Constipation is usually associated with a number
of diseases, and is characterized by a series of complex GI
symptoms in the absence of mechanical obstruction of the
GI tract [1, 2]. Diet, side effects of medication, and hormo-
nal disorders may induce constipation [3–5]. Therapy for
constipation is largely directed towards treating the
symptoms, and most of the treatment methods are
uniformly effective [6]. However, these treatments do not
address the underlying dysfunction in the GI tract that
results in constipation.
Acupuncture as one of the most frequently applied
methods in Traditional Chinese Medicine, which has a
history of more than 3000 years, has gained increased
popularity. In recent years, electroacupuncture (EA) at dif-
ferent acupoints has come to be recognized as a potential
effective therapy to treat GI disorder. Preclinical researches
have shown that ST 37 could increase GI transit, relieve
defecation difficulty and improve life quality [7–9], and
indicated that it is effective for constipation. Previous
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experiments have shown chronic and recurrent cold water
irritation to stomach might cause long-term effects on
bowel movements, which resulted in the GI motility, such
as inhibited jejunal and colonic motility [10, 11]. In a cold
water-induced rat model of constipation, EA stimulation at
ST 37 increases faecal water content, defaecation frequency
and GI transit [12, 13]. ST37 has a positive effect on object-
ive markers of constipation. It is believed that acupuncture
at different acupoints exerts different effects on internal
organs to restore the homeostatic balance [14–16]. Most
previous research has focused on the effects on central and
peripheral neural pathways in EA’s ameliorating effects on
intestinal motility [17]. However, the effects and mecha-
nisms of EA on the enteric nervous system (ENS) have not
been widely investigated. The purpose of this study was to
investigate whether EA affects the ENS, and to explore
local neural mechanism of EA in the gut.
Methods
Animals
C57BL/6 J mice (SPF-grade, 3-week-old males, 20–25 g)
were purchased from the Model Animal Research Center
of Nanjing University (Nanjing, China, license number:
SCXK 2013–0005). Animals were housed in a room with
12 h light–dark cycle (turn on at 8:00 a.m.) maintained at
22 ± 2 °C with 60 % humidity and ad libitum access to
food and water. All experimental manipulations were
undertaken in accordance with the Principles of Labora-
tory Animal Care and the Guide for the Care and Use of
Laboratory Animals, published by the National Science
Council, China.
Experimental model of constipation
The mice were randomly divided into two groups: a 0–4 °C
saline-treated group (n = 40), and a normal feeding group
(n = 10), randomly numbered, and raised in single cages
that allowed normal access to food and water. Wire netting
was used to facilitate the separation and collection of stools.
The constipation model was established by gastric instilla-
tion of ice-cold (0–4 °C) saline daily for 14 days [18]. To
eliminate the influence of biological rhythms, intragastric
administrations were conducted at 8:00 am daily for 14 d.
Animals were initially administered ice-cold (0–4 °C) saline
at a dose of 0.2 mL/mouse, and then the dose was
increased by 0.05 mL/mouse every 5 d. Control mice were
raised normally without intragastric administration of
ice-cold saline.
Materials
Materials used in this study include wire netting (to
facilitate the separation and collection of stools); a
precision electronic balance (Sartorius Co, Beijing, China);
ceramic cups (high temperature-resistant, radius: 2 cm,
high: 3.5 cm).
Drugs included saline (Sodium chloride injection;
Nanjing Chemical Reagent Co, Jiangsu, China), acacia gum
(Gum Arabic powder; BASF Chemical Co, Tianjin, China),
and black or red carbon powder (Color toner; Sanheng
Information Technology Co). Primary antibodies for immu-
nohistochemistry included PGP9.5 (Abcam, Cambridge,
UK) and nNOS (Abcam, Cambridge, UK). The secondary
antibody used was HRP-Polymer Rabbit anti-Mouse IgG
(Boster Biotech, Wuhan, China).
Black and red carbon suspensions were prepared as
follows: acacia gum (100 g) was added to 800 mL of
water and boiled until transparent. Then the solution
was mixed with black or red carbon powder (50 g) and
boiled three times. After cooling, each solution was
diluted with water to 1000 mL and then stored at 4 °C.
The solutions were agitated prior to use.
EA treatment
After the constipation model was successfully established,
the constipated mice were randomly subdivided into two
groups (n = 6 for each group): the model group, which
remained untreated, and the EA group, which received
EA at ST 37. EA stimulation was applied by two pairs of
stainless steel needles (0.25 mm in diameter) inserted
bilaterally at ST 37 (2 mm lateral to the anterior tubercle
of the tibia and 6 mm below the knee joint) [19]. After in-
sertion into the acupoint of constipated mice, the needles
were stimulated by an EA apparatus (#HANS-100A, Nan
Jing Ji Sheng Medical Treatment Science and Technology
Co., China). Electrical stimulus intensity was set at 1 mA
with a frequency of 2-15Hz. The stimulation was delivered
for 15 min a day for 3 days.
Measurement of intestinal function
After 12 h of fasting, mice were intragastrically adminis-
trated a suspension of black carbon (0.3 mL) and killed
10 min later via cervical dislocation. The section of
intestine extending from the pylorus to the ileocecal valve
was removed. The full length of the intestinal tract as well
as the propulsive distance of black carbon in the tract was
measured under a tension-free state, and the ratio of the
propulsive distance to the length of the intestinal tract was
determined for all groups. Additionally, after 12 h of fasting,
another group of mice were given a red carbon suspension
(0.3 mL), and the time required to defecate the first stool
pellet containing the red indicator was recorded.
Tissue preparation and immunohistochemistry
At the end of the experiment, small intestine (jejunum
and ileum) and proximal colon tissue specimens were
removed after 12 h of fasting. Segments approximately
1 cm in length were opened along the mesenteric border,
and immediately fixed by immersion in 4 % paraformal-
dehyde for 24 h. Then the samples were processed for
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paraffin embedding in vacuum and cut at a thickness of
10 μm for immunohistochemistry.
Sections were deparaffinized in xylene and hydrated in
a graded solution of ethanol. Activity of endogenous
peroxidases was blocked with 3 % hydrogen peroxide.
Sections were sequentially incubated in 3 % hydrogen
peroxide and blocked with 5 % bovine serum albumin
(BSA) for 30 min at 37 °C. The primary antibodies
(Abcam, Cambridge, UK) for PGP9.5 (1:1000) and nNOS
(1:800) were applied to the sections and each specimen
was incubated in a moist chamber overnight at 4 °C, and
then washed for three times in 0.01 mol/L phosphate-
buffered saline (PBS; pH 7.2). After that, the slides were
incubated with horseradish peroxidase (HRP)-Polymer
Rabbit anti-Mouse IgG(Boster Biotech, Wuhan, China)
for 90 min at 37 °C, then incubated in 3,3-diaminobenzi-
dine (DAB) solution for 2-5 min. Specificity of the
antibody was confirmed by negative control staining in
the absence of primary antibody treatment. Two
observers evaluated the slides using an Olympus FV500
optical microscope (Olympus, Tokyo, Japan). Positive
immunostaining was evaluated at 5 random visual fields
at a magnification of 400. The mean density of positive
expression was assessed using image analysis software
(Image Pro Plus 6.0).
Statistical analysis
Data were expressed as mean ± standard error Statistical
analysis was conducted using SPSS 17.0 software with one-
way analysis of variance. Data were compared using the
Student Newman Keuls post-hoc test. Differences where
P < 0.05 were considered to be statistically significant.
Results
Effects of EA stimulation on small intestine function
Carbon intestinal propulsion experiments showed the
distances by which black carbon was propelled
decreased in constipation models compared to control
group (Fig. 1a, P < 0.05). After EA treatment, carbon
propulsion rates significantly increased, and did not
differ from control group values (Fig. 1b).
Fig. 1 Measurement of carbon propulsion rate. a: All groups were used in the intestinal propulsion experiment. The distances traveled by black
carbon significantly increased in the EA group compared to the Model group. b: Examples of intestine and black carbon trace for all three
groups. (n = 6 for each group), #P < 0.05 vs. Control or EA group
Fig. 2 Measurement of the defecation time. All groups were used in
tracking time required for defecation of the first indicator-containing
stool pellet. (n = 6 for each group), #P < 0.01 vs. Control or EA group
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Effects of EA stimulation on defecation time
In this experiment, the defecation time was prolonged in
constipation models compared to control group, as
would be expected. After EA stimulation treatment,
defecation time significantly decreased compared to con-
stipation models and almost returned to normal (Fig. 2).
Effect of EA on total neuronal PGP9.5 protein expression
Immunohistochemical staining revealed that the number
of PGP9.5-positive cells in the constipation model was
markedly decreased compared with the control group in
the small intestine and proximal colon. After EA treat-
ment, the protein expression of PGP9.5 was significantly
increased compared to constipation models in jejunum
(Fig. 3a, b, c), ileum (Fig. 3e, f, g) and proximal colon
(Fig. 3i, j, k), but there was no difference compared with
the control group, respectively (Fig. 3d, h, l).
Effects of constipation and EA stimulation on nNOS
protein expression
Statistical analysis indicated that the expression of nNOS
in constipation models were increased compared with
the control group in the in jejunum, ileum and proximal
colon. After EA at ST 37, the expression of nNOS was
significantly decreased compared to constipation models
in jejunum (Fig. 4a, b, c), ileum (Fig. 4e, f, g) and prox-
imal colon (Fig. 4i, j, k), almost returned to normal levels
Fig. 3 Effects on total neurons-PGP9.5 protein expression in immunohistochemical staining. Tissue with brown granular deposits indicate positive
immunostaining (arrows) Scale bar: 40 μm, magnification: ×400. a, b, c: In jejunum; e, f, g: In ileum; i, j, k: In proximal colon; d, h, l: Comparison of
the mean density of PGP9.5-positive expression, respectively. *P < 0.01 vs. Control group; #P < 0.05 vs. EA group, n = 5 for each group
Liang et al. BMC Complementary and Alternative Medicine  (2016) 16:392 Page 4 of 7
and there was no difference compared with the control
group, respectively (Fig. 4d, h, l).
Discussion
Acupuncture is beneficial as an alternative treatment for
the management of gastrointestinal functional disorders,
including constipation, diarrhea and irritable bowel
syndrome [20–22]. Although acupuncture has been used
as an appropriate adjunct treatment for GI dysfunction
disorders, the underlying mechanisms of EA on the ENS
have not been well studied.
In this study, the results indicate that EA at ST 37
improved impaired intestine functions, accelerating GI
motility. Acupuncture is recognized to have regionally
specific effects [23]. ST 37 is located in the hind limb,
and some studies have demonstrated that acupuncture
at the hind limb increases GI motility [24]. In clinical
treatment, ST 37 can improve GI motility and alleviate
symptoms, which is effective for treating constipation
[25, 26]. Previous research has focused on the effects of
acupuncture on central and peripheral neural pathways;
EA stimulation of points on the abdomen can influence
sympathetic nerves to the GI tract, while points in the
four limbs can influence parasympathetic nerves [27, 28].
Parasympathetic nerves can promote GI peristalsis, while
sympathetic nerves inhibit GI movement [29]. Accord-
ingly, the effect of stimulation at ST 37 support these
previous results. Stimulation at ST 37 may increase the
Fig. 4 Effects on nNOS expression in immunohistochemical staining. Tissue with brown granular deposits indicate positive immunostaining
(arrows) Scale bar: 40 μm, magnification: ×400). a, b, c: In jejunum; e, f, g: In ileum; i, j, k: In proximal colon; d, h, l: Comparison of the mean
density of nNOS-positive expression, respectively. *P < 0.01 vs. Control group; #P < 0.05 vs. EA group, n = 5 for each group
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parasympathetic-sympathetic balance and promote GI
movement. As the ENS plays an important role in the GI
motility, we hypothesized that the ENS could participate in
EA stimulation of GI function. The ENS is a complex
network of neurons and glia that resides in the myenteric
and submucosal plexus of the bowel, and controls many
aspects of bowel function [30]. The myenteric plexus,
located between longitudinal and circular muscle, primarily
controls muscle contraction and relaxation [31]. Therefore,
ENS defects may underlie common GI motility problems
such as constipation.
Our previous study indicated that irritation with ice-
cold saline caused changes in the ENS in the jejunum,
ileum and proximal colonic myenteric plexus [18]. Indeed,
immunohistochemistry results showed the protein expres-
sion of PGP9.5 after EA stimulation was significantly in-
creased compared to constipation models in the jejunum,
ileum and proximal colon myenteric plexus. PGP9.5 is a
neuron-specific protein, which can be used to accurately
locate enteric neurons and indicate ENS function [32]. In
this study, our results indicated that EA may improve en-
teric neurons and repair the impaired ENS. A previous
study found that EA at ST 36 (Zusanli), which is also
located in the hind limb, can induce regeneration of lost
enteric neurons in a diabetic model [33]. Thus, the enteric
neurons in the ENS are likely to be affected by EA
stimulation. As we know, abnormal activity of the ENS
can have significant effects on the functions of the digest-
ive tract, and many diseases illustrate essential roles of the
ENS [34, 35]. In our opinion, EA ameliorates intestinal
motility impairment through both central and peripheral
neural pathways, which works in concert with the ENS.
Furthermore, the expression of neuronal nitric oxide syn-
thase (nNOS) in the constipation model was significantly
increased compared with the control group, and returned
to almost normal after EA treatment. In the ENS, nitric
oxide (NO) is a major inhibitory neurotransmitter, and is
synthesized by neuronal NOS [29]. It has been suggested
that, in the ENS, structural abnormalities of the myenteric
and submucosal plexus and an abnormal neurotransmitter
content have been considered to be responsible for primary
chronic constipation [36]. Studies on different parts of the
intestine reveal the participation of NO in the regulation of
spontaneous contractions, such as colonic contractile
activity [37, 38]. We concluded from our experiments that
increased NO in the myenteric plexus might reduce intes-
tinal motility, and be closely related to the development of
constipation. In our view, EA at ST 37 can restore the bal-
ance of inhibitory neurotransmitters of the enteric neurons,
leading to improvement of the impaired ENS function.
Conclusion
In summary, EA stimulation at ST 37 is capable of
ameliorating intestinal motility dysfunction in a mouse
constipation model, and can partly restor e enteric
neuron function. The ENS can participate in changes in
intestinal motility by affecting inhibitory neurons. EA
could effects on internal organs, and restore the homeo-
static balance via central and peripheral neural pathways
working in concert with the ENS.
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